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Prominent autistic traits and subthreshold bipolar/mixed
features of depression in severe anorexia nervosa
Michele Fornaro,10000-0000-0000-0000 Teresa Sassi,1 Stefano Novello,1 Annalisa Anastasia,2 Andrea Fusco,1
Ignazio Senatore,1 Andrea de Bartolomeis1
1Dipartimento di Neuroscienze, Sezione di Psichiatria, Universita` Federico II di Napoli, Italy. 2Istituto Nazionale di Previdenza Sociale, Latina,
Italy.
Objective: Autistic traits are associated with a burdensome clinical presentation of anorexia nervosa
(AN), as is AN with concurrent depression. The aim of the present study was to explore the intertwined
association between complex psychopathology combining autistic traits, subthreshold bipolarity, and
mixed depression among people with AN.
Method: Sixty patients with AN and concurrent major depressive episode (mean age, 22.267 years)
were cross-sectionally assessed using the Autism-Spectrum Quotient test (AQ-test), the Hamilton
depression scales for depression and anxiety, the Young Mania Rating Scale (YMRS), the
Hypomania-Checklist-32 (HCL-32), second revision (for subthreshold bipolarity), the Brown Assess-
ment and Beliefs Scale (BABS), the Yale-Brown-Cornell Eating Disorders Scale (YBC-EDS), and the
Eating Disorder Examination Questionnaire (EDE-Q). Cases were split into two groups depending on
body mass index (BMI): severe AN (AN+) if BMI o 16, not severe (AN-) if BMI X 16.
Results: The ‘‘subthreshold bipolarity with prominent autistic traits’’ pattern correctly classified 83.6%
of AN patients (AN+ = 78.1%; AN- = 91.3%, Exp(B) = 1.391). AN+ cases showed higher rates of
positive scores for YMRS items 2 (increased motor activity-energy) and 5 (irritability) compared to AN-
cases.
Conclusions: In our sample, depressed patients with severe AN had more pronounced autistic traits
and subtly mixed bipolarity. Further studies with larger samples and prospective follow-up of treatment
outcomes are warranted to replicate these findings.
Keywords: Anorexia nervosa; autism spectrum; bipolar disorder; mixed depression
Introduction
Accumulating evidence suggests a relationship between
autism spectrum disorders (ASDs) and anorexia nervosa
(AN).1-3
An underlying genetic vulnerability shared by AN and
ASDs has been proposed since the late 1980s, with
research pointing out prominent AN features in (pre-)
adolescent females and autistic features in infant males,
following the interaction of certain environmental factors.4
Elevated autistic traits have also been reported in females
with AN,5,6 as have morphometric alterations in brain
areas linked to social cognition, including the amygdala,
the orbitofrontal cortex, the fusiform face area (in the tem-
poral lobe and Brodmann’s area 37), and the supe-
rior temporal sulcus.7,8 Overall, the prevalence of ASD in
AN has been reported to approximate 23% of cases.9
This is a compelling finding, taking into account the simi-
larities in cognitive, social, and emotional processing
between AN and ASD.10,11 These similarities pertain
attention-switching tasks, perspective taking and fantasy,
lack of emotional introspection, and the theory of mind
profile,12 and have led to the conceptualization of AN as a
distinct female autism phenotype.1 The presence of autistic-
spectrum features in AN is associated with a more severe
clinical presentation, depression, anxiety, and poorer
everyday functioning overall.13,14 Poorer treatment out-
comes of AN have been documented in patients with trait-
like (stable) ASD features,15 possibly leading to multiple
treatment-augmentation attempts and polypharmacy.16
The impact of ASD on the outcomes of AN treatment
deserves research attention, especially considering that
ASD is associated with a fourfold increase in lifetime dep-
ression rates17 and that adults with prominent autistic
traits have high rates of suicide attempts.18 Little attention
has been given to the impact of depression in this parti-
cular population, although clinical practice suggests a
high burden of depression (often associated with irritability
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and increased motor-activity/energy expenditure, possibly
seen as subtle hints of bipolarity) and prominent autistic
traits in AN.
To the best of our knowledge, no research has been
published concerning the potential impact of concurrent
depression (herein including subthreshold bipolar depres-
sion) and autistic traits on body mass index (BMI) scores
in AN, a parameter otherwise regarded as a hallmark of
severity in the DSM-5.19
However, we hypothesize that the presence of autistic
traits and subthreshold bipolarity with mixed features may
be more pronounced among severe AN people with a
current major depressive episode (MDE).
Therefore, the present study aims at preliminary
assess the impact of depression and autistic traits on
the severity of AN, ideally paving the ground for future
prospective studies providing a systematic neuropsycho-
logical and treatment-outcome assessment.
Methods
The procedures adopted in the present cross-sectional
study are outlined below, following the recommendations
of the Strengthening the Reporting of Observational
Studies in Epidemiology (STROBE) statement.20
Study setting, participants, and eligibility criteria
In- and outpatients of both sexes, aged 14 years or older,
with a primary diagnosis of AN and comorbid MDE, either
in the course of major depressive disorder (MDD) or bip-
olar disorder (BD), were screened for inclusion. Given
the non-experimental design of this study, the inclusion
criteria were very permissive.
Enrollment took place in January 2017 and October
2018, at the outpatient psychiatric unit of Federico II
University of Naples, Italy. Two experienced psychiatrists
(TS and IS) were appointed to establish the diagnoses
according to the DSM-5 criteria. The exclusion criteria
were substance use disorder, lack of valid informed con-
sent, and any condition potentially affecting BMI. Finally,
AN subjects were split into two groups: severe (AN+) if
BMI o 16 or non-severe (AN-) if BMI X 16, as per the
DSM-5 threshold.
Variables, measures, and procedures
Once demographic and clinical data had been gathered, a
broad range of rating tools were administered. The Autism-
Spectrum Quotient-test (AQ-test), Italian-language ver-
sion,21 has also been validated for use with patients with a
primary diagnosis of AN.10 The AQ-test includes 50 items
assessing five areas of functioning: social skill, attention
switching, attention to detail, communication, and imagina-
tion. The Hamilton Rating Scale for Depression 17-item
version (HAM-D-17)22 and Anxiety (HAM-A)23 and the
Young Mania Rating Scale (YMRS) were administered to
all participants. Additionally, the Hypomania Checklist-32-
item, second revision (HCL-32-R2, 34-item version), was
used to test for presence of subthreshold bipolarity among
participants with a DSM-5 diagnosis of unipolar major
depression. The severity and the type of eating disorder
were self-reported using the Yale-Brown-Cornell Eating
Disorders Scale (YBC-EDS)24 and the Eating Disorder
Examination Questionnaire (EDE-Q).25 The YBS-EDS
assess both current and ‘‘worst ever’’ scores for rituals
and preoccupations about a range of habits and somatic
features. The EDE-Q comprises three domains: restraint,
eating concern, and weight concern. Finally, a multi-
purpose scale for the assessment of insight of illness, the
Brown Assessment and Beliefs Scale (BABS),26 was
administered.
On all of the aforementioned scales, higher scores indi-
cate a higher symptom burden. Patients’ clinical records
were anonymized and pooled for the present analysis.
Statistical analysis
All statistical analyses were performed in SPSS version
25.0 for Windows, adopting an alpha error rate of 0.05
(two-tailed) and a conservative statistical power of 95%.
Interrater reliability for the analysis was ascertained
preliminarily using Cohen’s k statistic, to ensure consis-
tency of clinician-administered ratings among raters and
minimize rating bias. The normality of data distribution
and the homogeneity of variance were verified using the
Kolmogorov-Smirnov and Levene tests, respectively.
Parametric comparative analyses for demographic and
clinical characteristics of the groups were performed
using an independent-samples Student t-test for contin-
uous variables where appropriate (with the Wilcoxon
rank-sum test planned for nonparametric distributions)
and chi-square analysis for categorical variables (again,
nonparametric as appropriate). Pearson’s or Spearman’s
rho correlations were calculated for selected clinical varia-
bles as appropriate. Binary logistic regression (dependent
variable = AN+/AN-) was carried out using the conditional
backward logistic regression method for those variables
having a significantly different distribution between the
AN+ vs. AN- groups upon descriptive analysis; linear
regression analysis using BMI as a dependent variable
followed the logistic regression. Finally, missing data were
excluded pairwise.
Ethics statement
The participating patients provided a valid, written
informed consent after two experienced psychiatrists
(TS and IS) had thoroughly explained the study proce-
dures, according to the norms outlined by the local ethics
committee.
Results
Among 72 potentially eligible patients screened, 60 were
confirmed eligible for inclusion. Of these, 56 had MDD;
three had BD-II (two AN+ and one AN-); and one (AN+)
had BD-I. Excluded patients either failed to meet the
diagnostic criteria of a current MDE (n=10) or refused
consent due to privacy concerns (n=2).
The sample included 55 females (F) and five males
(M). Overall, 35 patients were rated as AN+ (F/M = 31/4)
Braz J Psychiatry. 2020;42(2)
154 M Fornaro et al.
and 25 as AN- (F/M = 24/1). The age of the AN+ patients
ranged from 14-46 years (mean 6 standard deviation
[SD] = 22.8266.99); 26 were adult (aged 18 years or
older). In the AN- group, age ranged between 15-45 years
(mean6 SD = 21.3267.16), of whom 18 were adult. Most
AN+ cases were inpatients at the time of assessment (27
of 35, 77.1%), in contrast to the AN- cases (6 of 25, or 24%
of cases). Additional demographic and clinical features are
described in Table 1.
Interrater variability
The preliminary interrater variability for diagnosis of
current MDE (HAM-D-17 total score X 7) was k = 0.749
(p p 0.001), 95% confidence interval (95%CI) -0.0710
to 0.1038, denoting substantial agreement. Additional
measures of interrater variability for other non-self-report
ratings ranged from 0.72 (substantial agreement) to 0.83
(almost perfect agreement).
Selected correlation measures in the AN+ group
Figure 1 provides a pictorial synthesis of the correlation
between BMI and YMRS total scores in the AN+ and AN-
groups.
Essential correlation metrics in the AN+ and AN- groups
are reported in Table 2.
YMRS items 2 (increased motor activity-energy) and
5 (irritability) correlated significantly with AN+: rs = 0.452
(p p 0.001) and rs = 0.406 (p p 0.001), respectively.
YMRS item 5 also correlated with AQ-test total score in AN:
rs = 0.353 (pp 0.001). The strongest and most significant
(positive) correlation in the AQ-test subset was found
between AQ-test attention switching and EDE-Q shape, in
the AN+ group only (r = 0.492, p p 0.001).
Essential multivariate statistics
A backward (conditional) stepwise binary logistic regres-
sion analysis was conducted to allocate patients to either
the AN+ or the AN- group, accounting for autistic traits
measured using the AQ-test scale and subthreshold
bipolarity scores recorded with the HCL-32-R2, among
other predictors.
A test of the full model against a constant-only model
was statistically significant, indicating that the predic-
tors as a set reliably discriminated between AN+/- cases:
(w2 [2] = 27.409; p p 0.001). Nagelkerke’s R2 = 0.528 indi-
cated a sound explanatory value of the regression model.
Overall AN predictive capacity was 83.6% (AN+ = 78.1%;
AN- = 91.3%).
Additional variables were likewise included in the
multistep procedure outlined in Table 3, although step 6
of the logistic regression (AQ-test and HCL-32-R2 total
scores input as covariates) provided the best fit, possibly
due to multicollinearity issues as well. The Wald criterion
demonstrated that both AQ-test total (p = 0.039) and
HCL-32-R2 total (p = 0.001) made significant contribu-
tions to the prediction, with prominent autistic traits and
higher HCL-32-R2 scores providing odd ratios (OR) –
(Exp[betas]) – of roughly 1.2 and 1.4, respectively, for
prediction of AN+ vs. AN- categorization. For purposes of
convenience and ease of interpretation, an OR = 1 indi-
cates the same propensity of an event belonging to a
given AN subgroup.
Linear regression analysis using BMI total score as
the dependent variable and AQ-test and HCL-32-R2
total scores as covariates indicated that the model
predicted the BMI scores of AN patients (adjusted R2 =
0.383; p p 0.001). However, only the standardized b
coefficient of AQ-test was significant (p p 0.001).
Discussion
The primary aim of the present study was to explore
severe AN through correlations with complex psycho-
pathology (combining autistic traits, mixed features, and
subthreshold bipolarity) among patients presenting with a
MDE. As expected, descriptive analyses indicated that
AN+ cases were more frequently inpatients, on pharma-
cological treatment (especially benzodiazepines or anti-
psychotics), had higher rates of lifetime psychiatric
hospitalization, and had significantly higher scores on all
domains of the YBC-EDS and global EDE-Q compared to
AN-. Consistent with previous research,10-12 the preli-
minary results of the present study indicate that severe
AN is associated with higher scores on the AQ-test com-
pared to AN-, especially in the attention-switching and
communication domains.
Multiple lines of research support the connection
between ASD and AN, including shared neurobiology7,8
and genome-wide association studies.27 Elevated ASD
traits are associated with lower BMI scores, suggesting
that ASD traits may arise from the starved state of AN28
and thus warrant follow-up over the natural history and
treatment course of AN. The relationship between AN and
ASD is nonspecific, so that ASD traits could be over-
represented in AN, perhaps even maintaining the asso-
ciated eating disorder rather than causing it.13 It has been
hypothesized that rigidity, obsessive interest, and social
withdrawal/impairments could be the manifestations of an
underlying ASD or may be the consequences of highly
prevalent conditions in AN, such as starvation, anxiety,
depression, and obsessive-compulsive disorder.29 The
label of ‘‘severe’’ AN proposed by the DSM-5 based solely
on BMI, as we adopted in the present study, may there-
fore insufficient to capture the complexity of the phenom-
enon of AN, especially when combined with prominent
autistic traits and depression, both of which may have a
pathoplastic effect of AN. Similarly, very low BMI could
induce agitation, hyperactivity, problematic physical activ-
ity30 and other bipolar-like symptoms through anaerobic
(ketotic) metabolism; thus, we cannot rule out that at least
part of the psychopathological features associated with
AN+ could be explained as ‘‘soft bipolarity’’ due to severe
metabolic disturbances and malnutrition, which is a con-
dition known to predict inadequate response towards
standalone antidepressant drugs31 (indeed, roughly half
of the AN+ patients in our sample were on antidepres-
sants). If corroborated by prospective follow-up, changes
in BMI scores in the AN+ subgroup may explain at least
part of the bipolar-like and autism-spectrum symptoms
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Table 1 Demographic and clinical features of the subjects included in the study
Study subjects (n=60) Severe AN n=35 (58%) Non-severe AN n=25 (42%) t or w2(df) p-value
Demographics
Age in years, mean 6 SD (range) 22.8266.99 (14-46) 21.3267.16 (15-45) -0.816(58) ns
Female-to-male ratio, n (%) 31 (88.6)/4 (11.4) 24 (96.0)/1(4.0) 1.054(1) ns
Education level
Primary 1 (2.9) 0 (0.0) 5.362(3) ns
Secondary 16 (45.7) 19 (72.0)
Higher 16 (45.7) 5 (20.0)
College or university 2 (5.7) 2 (8.0)
Clinical features
BMI 14.0761.44 17.1260.91 9.334(58) o 0.001
Duration of untreated illness, years (mean 6 SD) 5.6864.17 4.0866.05 -1.161(58) ns
Age at onset, years (mean 6 SD) 17.266.22 17.2464.78 -0.027(58) ns
Current MDE 35 (100.0) 25 (100.0) ns
Current mixed features (DSM-5 defined) 16 (45.7) 4 (16.0) 5.794(1) 0.016
Purging type 9 (25.7) 6 (24.0) 0.023(1) ns
Lifetime MDD 32 (91.4) 24 (96.0) 0.490(1) ns
Lifetime BD-II 2 (5.7) 1 (4.0) 0.090(1) ns
Lifetime BD-I 1 (2.9) 0 (0.0) 0.726(1) ns
Lifetime OCD 5 (14.3) 2 (8.0) 0.559(1) ns
Lifetime anxiety disorders other than OCD 10 (28.6) 5 (20.0) 0.571(1) ns
Lifetime BN 7 (20.0) 5 (20.0) 0.000(1) ns
Lifetime BED 3 (8.6) 0 (0.0) 2.256(1) ns
Lifetime suicidal behavior 6 (17.1) 3 (12.0) 0.303(1) ns
Lifetime hospitalization 17 (48.6) 3 (12.0) 8.777(1) 0.003
Currently on pharmacotherapy (any type) 31 (88.6) 12 (48.0) 11.822(1) 0.001
Currently on antidepressant 16 (45.7) 9 (36.0) 0.566(1) ns
Currently on benzodiazepines 21 (60.0) 6 (24.0) 7.636(1) 0.006
Currently on second-generation antipsychotic 14 (40.0) 1 (4.0) 10.08(1) 0.001
Currently on lithium 0 (0.0) 1 (4.0) 1.42(1) ns
Currently on other mood stabilizer 1 (2.9) 4 (16.0) 3.29 ns
Family history of eating disorders 3 (8.6) 1 (4.0) 0.49(1) ns
Family history of affective disorders 10 (28.6) 8 (32.0) 0.082(1) ns
Family history of anxiety disorders other than OCD 11 (31.4) 6 (24.0) 0.396(1) ns
Family history of suicidal behavior 0 (0.0) 0 (0.0) ns
Family history of OCD 3 (8.6) 1 (4.0) 0.490(1) ns
Inpatient status 27 (77.1) 6 (24.0) 16.641(1) o 0.001
Number of previous hospitalizations (mean 6 SD) 0.7461 0.260.5 -2.416(58) 0.019
AQ-test total score (mean 6 SD) 24.2565.29 20.0464.46 -3.241(58) 0.002
Attention switching 7.1161.07 5.3261.51 -5.35(58) o 0.001
Attention to detail 3.4861.24 3.4061.19 -0.268(58) ns
Communication 3.9461.58 361.08 -2.570(58) 0.013
Imagination 3.0861.19 3.9461.58 -2.570(58) ns
Social skills 6.6261.68 5.8861.3 -1.861(58) ns
ADHD 2 (5.7) 0 (0.0) 1.478(1) ns
HCL-32-R2 total score* (mean 6 SD) 7.7865.05 4.3463.94 -2.714(58) 0.009
Rating scales
HAM-D-17, total score (mean 6 SD) 17.7465.19 13.463.35 -3.663(58) 0.001
YMRS, total score (mean 6 SD) 7.5164.04 3.462.56 -4.476(58) o 0.001
YMRS, item 2 (increased motor activity-energy) recoded
as yes/no
23 (65.7) 5 (20.0) 12.245(1) o 0.001
YMRS, item 5 (irritability) recoded as yes/no 29 (89.2) 11 (44.0) 9.909(1) 0.002
YMRS, item 7 (language-thought disorder) recoded as
yes/no
8 (22.9) 5 (20.0) 0.070(1) ns
YMRS, item 9 (disruptive-aggressive behavior) recoded
as yes/no
8 (22.9) 3 (12.0) 1.148(1) ns
HAM-A total score (mean 6 SD) 13.3464.23 10.8863.19 -2.45(58) 0.017
BABS total score (mean 6 SD) 8.5164.69 8.1265.55 -0.297(58) ns
YBC-EDS (mean 6 SD)
Total, current 33.8565.32 29.6465.16 -3.096(58) 0.003
Total, worst 34.6265 30.7664.42 -3.06(58) 0.003
Total, current rituals 11.0561.89 9.4461.70 -3.394(58) 0.001
Total, worst rituals 11.2561.8 9.8461.65 -3.106(58) 0.003
Total, current preoccupations 11.6861.77 9.861.89 -3.94(58) o 0.001
Total, worst preoccupations 11.8861.71 10.1262.04 -3.63(58) 0.001
Continued on next page
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upon improvement of imbalances due to anaerobic meta-
bolism and vigorous physical exercise. However pre-
liminary, the results of the present study suggest that
DSM-5 mixed features of depression were significant
more prevalent among AN+ vs. AN- cases, regardless of
the putative causes. Furthermore, increased motor-
activity/energy and irritability were also more common
among those AN individuals with lower BMI scores,
although not significantly so. This has major clinical
implications, considering that neither ‘‘increased motor-
activity/energy’’ nor ‘‘irritability’’ are included by the DSM-
5 among the mixed features, despite their discriminant
predictive value for bipolarity in the clinical setting.32
Likewise, the higher HCL-32-R2 scores detected do not
necessarily indicate bipolarity in AN+ cases, since in
most instances the usual cutoff of 14 was not met. As the
HCL-32-R2 has not yet been validated for use in patients
with DSM-5-defined unipolar depression associated with
AN and prominent autistic traits, we submit that even a
trend towards higher HCL-32-R2 scores (significantly
higher in AN+ vs. AN- cases) may indicate a plausible
trend toward subthreshold bipolarity (once again, regard-
less of putative neuroendocrine causes). This is particu-
larly worth of note considering that the potential presence
of ‘‘signs of excitement’’ may account for a specific thera-
peutic approach, assuming an internal medicine workup
Figure 1 Pearson’s correlation of BMI and YMRS total score, r2 = -0.545; pp 0.001. BMI dichotomizes AN as severe (o 16)
or non-severe (X 16). This plot provides an estimate of the impact of manic-series symptoms in depression, and should
be considered a crude approximation of the impact of the ‘‘mixed features’’ DSM-5 specifier for MDE. AN = anorexia nervosa;
BMI = body mass index; MDE = major depressive episode; YMRS = Young Mania Rating Scale.
Table 1 (continued )
Study subjects (n=60) Severe AN n=35 (58%) Non-severe AN n=25 (42%) t or w2(df) p-value
EDE-Q (mean 6 SD)
Restraint subscale 22.463.79 19.5265.5 2.401(58) 0.020
Eating concern subscale 16.6564.57 14.4863.88 -1.932(58) ns
Shape concern subscale 28.2865.67 27.5668.23 -0.373(58) ns
Weight concern subscale 15.7764.62 16.2865.67 0.382(58) ns
Global 78.14614.28 75.44619.43 -2.405(58) 0.019
Data presented as n (%), unless otherwise specified.
ADHD = attention deficit and hyperactivity disorder; AN = anorexia nervosa; AQ-test = Autism-Spectrum Quotient test; BABS = Brown
Assessment and Beliefs Scale; BD = bipolar disorder; BED = binge eating disorder; BMI = body mass index; BN = bulimia nervosa; df =
degrees of freedom; EDE-Q = Eating Disorder Examination Questionnaire; HAM-A = Hamilton Anxiety Rating Scale; HAM-D-17 = Hamilton
Scale for Depression, 17-item; HCL-32-R2 = Hypomania Checklist, 32-item, second revision, 34-item version; MDD = major depressive
disorder; MDE = major depressive episode; ns = nonsignificant; OCD = obsessive-compulsive disorder; SD = standard deviation; YBC-EDS =
Yale-Brown-Cornell Eating Disorders Scale; YMRS = Young Mania Rating Scale.
*56/60 MDD patients.
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has already ruled out any underlying organic condition
which might affect attitudes toward eating. We hypothe-
size that, at least in a proportion of severe cases of AN,
the combination of prominent autistic traits and depres-
sion with irritability and increased motor-activity/energy,
alongside obsessive interests (i.e., a focus on shape con-
cerns) and an inability to divert attention switching toward
objects/goals other than eating and weight concerns,
may represent an atypical mixed state. According to Emil
Kraepelin and his pupil Wilhelm Weygandt, depres-
sion may accompany ‘‘psychomotor activity’’ and ‘‘formal
reasoning’’ in different ways, leading to multiple mixed
configurations.33 Possibly, at least some depressed AN+
patients may thus present with atypical manifestations of
two Kraepelinian mixed states, namely ‘‘depressive-anxious
mania’’ (low mood, increased psychomotor activity, and
increased formal reasoning) and ‘‘aroused depression’’ (low
mood, increased psychomotor activity, and reduced formal
reasoning). Alternatively, very severe AN with prominent
autistic traits may resemble Esquirol’s monomania, a sort
of ‘‘partial insanity’’ conceived as ‘‘single pathological
preoccupation in an otherwise sound mind’’34 (herein, the
goal-directed activity/hyperactivity is focused on shape
and diet). On the other hand, at least a proportion of
Table 3 Multistep logistic regression
95%CI for Exp(B)
Variables in the equation B p-value Exp(B) Lower bound Upper bound
Step 1
AQ-test total score 0.198 0.027 1.219 1.023 1.454
HCL-32 total score 0.366 0.016 1.442 1.071 1.940
YMRS
Item 2 1.637 0.095 5.137 0.754 35.002
Item 5 0.267 0.780 1.306 0.201 8.497
Item 7 -1.779 0.153 0.169 0.015 1.937
Item 9 -0.743 0.595 0.476 0.031 7.386
BABS total score -0.119 0.189 0.888 0.744 1.060
Constant -5.584 0.004 0.004
Step 2
AQ-test total score 0.202 0.023 1.224 1.028 1.456
HCL-32 total score 0.377 0.012 1.458 1.086 1.956
YMRS
Item 2 1.705 0.071 5.503 0.865 35.008
Item 7 -1.754 0.156 0.173 0.015 1.958
Item 9 -0.850 0.529 0.427 0.030 6.045
BABS total score -0.117 0.192 0.889 0.745 1.061
Constant -5.557 0.004 0.004
Step 3
AQ-test total score 0.207 0.019 1.230 1.035 1.461
HCL-32 total score 0.330 0.007 1.392 1.094 1.770
YMRS
Item 2 1.748 0.064 5.745 0.905 36.487
Item 7 -1.682 0.171 0.186 0.017 2.071
BABS total score -0.123 0.173 0.885 0.741 1.055
Constant -5.543 0.004 0.004
Step 4
AQ-test total score 0.166 0.041 1.180 1.007 1.383
HCL-32 total score 0.294 0.009 1.342 1.077 1.673
YMRS
Item 2 1.656 0.075 5.238 0.845 32.478
Item 7 -1.441 0.235 0.237 0.022 2.551
Constant -5.375 0.004 0.005
Step 5
AQ-test total score 0.172 0.031 1.188 1.016 1.390
HCL-32 total score 0.287 0.011 1.332 1.067 1.663
YMRS item 2 1.242 0.128 3.463 0.698 17.177
Constant -5.558 0.003 0.004
Step 6
AQ-test total score 0.165 0.039 1.179 1.008 1.380
HCL-32 total score 0.347 0.001 1.415 1.146 1.748
Constant -5.228 0.004 0.005
Step 6 provided the best fit, correctly classifying up to 78.1% of AN+ cases.
The HCL-32-R2 scores refer to 56/60 unipolar depression patients.
95%CI = 95% confidence interval; AN = anorexia nervosa; AQ-test = Autism-Spectrum Quotient-test; BABS = Brown Assessment of Beliefs
Scale; HCL-32 = Hypomania Checklist-32-item, second revision, 34-item version; YMRS = Young Mania Rating Scale.
Braz J Psychiatry. 2020;42(2)
Comorbidities in severe anorexia nervosa 159
patients with overt BD may experience lifetime weight
cycling (possibly alternating bulimic and anorexic phases)
which resemble manic-depressive excitement (vigorous
physical exercise and starvation, or intense binging/
purging), alternating with apparent remission of this
excitement, resulting in less disabling – yet transient –
eating disturbances.35,36
Ideally, future controlled trials should consider low-dose
lithium (upon careful evaluation of cardiac and renal
function) and/or antipsychotics (preferably agents with a
low propensity to cause cardiac arrhythmias and weight
gain, so as to minimize the subsequent risk of refeeding
syndrome) for the most severe cases of AN with sub-
threshold bipolar depression and/or psychotic features,
such as lack of insight of illness corroborated by high
BABS scores. If confirmed in replication studies including
prospective assessment of different treatment modalities,
the potential impact of subtle features associated with
some of the most severe cases of AN should affect
treatment response, as postulated for some MDD cases
which are devoid of AN comorbidity yet respond inade-
quately to medication due to subthreshold bipolarity.37-39
Nevertheless, these considerations should be made only
after first-line evidence-based treatments,40 including
intensive medical and psychological care,41,42 prove to
be ineffective.
Limitations of this study include the small sample size,
lack of neuropsychological/IQ testing, and absence of
recording of treatment outcomes, energy expenditure,
and exercise activity across different treatment interven-
tions. In addition, besides the statistical significance of the
corresponding p-values, the ORs for the pivotal predictors
‘‘autistic traits’’ (OR = 1.18) and ‘‘sub-threshold bipolar
depression’’ (OR = 1.34) only slightly exceed 1, meaning
that the association between such predictors and AN+ is
not definitive (refer to the last step of the regression model
in Table 3). The severity of AN was defined solely by
BMI threshold, as in the DSM-5. Frail patients with AN
may have presented with medical symptoms resembling
depression, and no AN control without depression was
included in the present study. Female cases were
overrepresented, although this reflects the natural history
of the condition itself. On the other hand, the ‘‘real-world’’
setting of the present study may have reduced the
chances of Berkson’s bias.
In conclusion, the findings of the present study must be
considered as explorative. No recommendation whatso-
ever about therapeutic choices can be inferred at this
time; any potential implications for treatment must be
viewed as a critical, yet theoretical, appraisal, relevant
only for forthcoming research on the topic. However,
considering the burden related to the complex clinical
phenotype of severe AN with comorbid depression and
prominent autistic traits and the absence of evidence on
the matter, even results warranting replication – such as
ours – should be reported in such a hard-to-capture
special population.43
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